ImmuCell
ICCC
10 hedge funds and large institutions have $613K invested in ImmuCell in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, reducing their positions, and 1 closing their positions.
37% more capital invested
Capital invested by funds: $447K → $613K (+$166K)
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$122K |
| 2 |
U
UBS
Zurich,
Switzerland
|
+$5.68K |
| 3 |
Renaissance Technologies
New York
|
+$3.91K |
| 4 |
SRC
Shufro Rose & Co
New York
|
+$2.35K |
| 5 |
Morgan Stanley
New York
|
+$1.79K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SRC
1
Shufro Rose & Co
New York
| $245K | +$2.35K | +600 | +1% |
|
|
SKK
2
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| $148K | +$122K | +31,293 | New |
|
|
3
Morgan Stanley
New York
| $142K | +$1.79K | +458 | +2% |
|
|
4
Renaissance Technologies
New York
| $52K | +$3.91K | +1,000 | +10% |
|
|
U
5
UBS
Zurich,
Switzerland
| $16K | +$5.68K | +1,452 | +78% |
|
6
Bank of America
Charlotte,
North Carolina
| $9K | – | – | – |
|
7
Creative Planning
Overland Park,
Kansas
| $1K | – | – | – |
|
|
EFS
8
Essex Financial Services
Essex,
Connecticut
| $112 | – | – | – |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| – | -$1K | -254 | Closed |
|
ICCC Hedge Fund Activity: Q3 2013 in Review
10 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2013, worth a combined $613K — up 37% from $447K a quarter earlier.
Fund positioning in ICCC was balanced in Q3 2013: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 0 trimmed.
The largest buyer was Shepherd Kaplan Krochuk, opening a new position worth an estimated $122K. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $1K sold.
- 10 institutional investors held ImmuCell (ICCC) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $613K of ImmuCell stock for Q3 2013, up 37% quarter-over-quarter.
- 1 fund opened new ImmuCell positions in Q3 2013 and 1 closed out, a net change of 0 holders.
- The largest ImmuCell buyer in Q3 2013 was Shepherd Kaplan Krochuk, an estimated $122K added.
- The largest ImmuCell seller in Q3 2013 was Tower Research Capital (TRC), an estimated $1K sold.
Based on aggregated 13F filings for Q3 2013.